Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has been assigned an average rating of “Hold” from the twenty-one analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month price objective among brokers that have covered the stock in the last year is $15.13.

A number of analysts recently issued reports on MDRX shares. Maxim Group reissued a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, November 3rd. Zacks Investment Research cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. Robert W. Baird upped their price target on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday, November 3rd. Jefferies Group LLC set a $17.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a report on Friday, August 25th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a report on Wednesday, September 27th.

Allscripts Healthcare Solutions (NASDAQ MDRX) traded down $0.09 on Monday, reaching $12.57. 1,372,500 shares of the company were exchanged, compared to its average volume of 2,359,948. The firm has a market cap of $2,271.16, a P/E ratio of 29.23, a PEG ratio of 2.24 and a beta of 1.35. Allscripts Healthcare Solutions has a 12-month low of $9.96 and a 12-month high of $14.45. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Given Average Rating of “Hold” by Analysts” was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/allscripts-healthcare-solutions-inc-mdrx-given-average-rating-of-hold-by-analysts/1701110.html.

In related news, President Richard J. Poulton sold 15,000 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $67,600.00. Following the transaction, the executive vice president now owns 196,607 shares in the company, valued at $2,658,126.64. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,000 shares of company stock valued at $473,800. Company insiders own 0.91% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. World Asset Management Inc lifted its stake in Allscripts Healthcare Solutions by 0.7% during the second quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock worth $146,000 after purchasing an additional 81 shares during the last quarter. Atlantic Trust Group LLC lifted its stake in Allscripts Healthcare Solutions by 0.3% during the second quarter. Atlantic Trust Group LLC now owns 32,900 shares of the software maker’s stock worth $420,000 after purchasing an additional 110 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Allscripts Healthcare Solutions by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock worth $338,000 after purchasing an additional 115 shares during the last quarter. Bank of Montreal Can lifted its stake in Allscripts Healthcare Solutions by 6.9% during the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock worth $135,000 after purchasing an additional 689 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its stake in Allscripts Healthcare Solutions by 0.3% during the second quarter. Retirement Systems of Alabama now owns 339,736 shares of the software maker’s stock worth $4,335,000 after purchasing an additional 893 shares during the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.